JP2011520992A5 - - Google Patents

Download PDF

Info

Publication number
JP2011520992A5
JP2011520992A5 JP2011510783A JP2011510783A JP2011520992A5 JP 2011520992 A5 JP2011520992 A5 JP 2011520992A5 JP 2011510783 A JP2011510783 A JP 2011510783A JP 2011510783 A JP2011510783 A JP 2011510783A JP 2011520992 A5 JP2011520992 A5 JP 2011520992A5
Authority
JP
Japan
Prior art keywords
topical composition
composition according
otitis media
eustachian tube
betahistine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011510783A
Other languages
English (en)
Japanese (ja)
Other versions
JP5543963B2 (ja
JP2011520992A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2009/000664 external-priority patent/WO2009143572A1/en
Publication of JP2011520992A publication Critical patent/JP2011520992A/ja
Publication of JP2011520992A5 publication Critical patent/JP2011520992A5/ja
Application granted granted Critical
Publication of JP5543963B2 publication Critical patent/JP5543963B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011510783A 2008-05-27 2009-05-27 エウスタキオ管機能障害を有する哺乳動物の治療方法 Expired - Fee Related JP5543963B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2008902659A AU2008902659A0 (en) 2008-05-27 Method of Treatment
AU2008902659 2008-05-27
PCT/AU2009/000664 WO2009143572A1 (en) 2008-05-27 2009-05-27 Methods of treating mammals with eustachian tube dysfunctions

Publications (3)

Publication Number Publication Date
JP2011520992A JP2011520992A (ja) 2011-07-21
JP2011520992A5 true JP2011520992A5 (https=) 2012-05-17
JP5543963B2 JP5543963B2 (ja) 2014-07-09

Family

ID=41376479

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011510783A Expired - Fee Related JP5543963B2 (ja) 2008-05-27 2009-05-27 エウスタキオ管機能障害を有する哺乳動物の治療方法

Country Status (14)

Country Link
US (1) US8642631B2 (https=)
EP (1) EP2293794B1 (https=)
JP (1) JP5543963B2 (https=)
KR (1) KR101621726B1 (https=)
CN (1) CN102046170B (https=)
AU (1) AU2009253739B2 (https=)
BR (1) BRPI0912126A2 (https=)
CA (1) CA2765190C (https=)
DK (1) DK2293794T3 (https=)
EA (1) EA022565B1 (https=)
ES (1) ES2419204T3 (https=)
NZ (1) NZ589742A (https=)
PT (1) PT2293794E (https=)
WO (1) WO2009143572A1 (https=)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10105592A1 (de) 2001-02-06 2002-08-08 Achim Goepferich Platzhalter zur Arzneistofffreigabe in der Stirnhöhle
US8317816B2 (en) 2002-09-30 2012-11-27 Acclarent, Inc. Balloon catheters and methods for treating paranasal sinuses
US8435285B2 (en) * 2003-11-25 2013-05-07 Boston Scientific Scimed, Inc. Composite stent with inner and outer stent elements and method of using the same
US7462175B2 (en) 2004-04-21 2008-12-09 Acclarent, Inc. Devices, systems and methods for treating disorders of the ear, nose and throat
US20070208252A1 (en) * 2004-04-21 2007-09-06 Acclarent, Inc. Systems and methods for performing image guided procedures within the ear, nose, throat and paranasal sinuses
US9399121B2 (en) 2004-04-21 2016-07-26 Acclarent, Inc. Systems and methods for transnasal dilation of passageways in the ear, nose or throat
US8747389B2 (en) 2004-04-21 2014-06-10 Acclarent, Inc. Systems for treating disorders of the ear, nose and throat
US8764729B2 (en) 2004-04-21 2014-07-01 Acclarent, Inc. Frontal sinus spacer
US20060004323A1 (en) 2004-04-21 2006-01-05 Exploramed Nc1, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US7559925B2 (en) 2006-09-15 2009-07-14 Acclarent Inc. Methods and devices for facilitating visualization in a surgical environment
US9554691B2 (en) 2004-04-21 2017-01-31 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US7419497B2 (en) 2004-04-21 2008-09-02 Acclarent, Inc. Methods for treating ethmoid disease
US20060063973A1 (en) 2004-04-21 2006-03-23 Acclarent, Inc. Methods and apparatus for treating disorders of the ear, nose and throat
US9101384B2 (en) 2004-04-21 2015-08-11 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat
US9351750B2 (en) 2004-04-21 2016-05-31 Acclarent, Inc. Devices and methods for treating maxillary sinus disease
US8702626B1 (en) 2004-04-21 2014-04-22 Acclarent, Inc. Guidewires for performing image guided procedures
US7654997B2 (en) 2004-04-21 2010-02-02 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat
US20190314620A1 (en) 2004-04-21 2019-10-17 Acclarent, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US10188413B1 (en) 2004-04-21 2019-01-29 Acclarent, Inc. Deflectable guide catheters and related methods
US8932276B1 (en) 2004-04-21 2015-01-13 Acclarent, Inc. Shapeable guide catheters and related methods
US7803150B2 (en) 2004-04-21 2010-09-28 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US9089258B2 (en) 2004-04-21 2015-07-28 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US20070167682A1 (en) * 2004-04-21 2007-07-19 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US8894614B2 (en) 2004-04-21 2014-11-25 Acclarent, Inc. Devices, systems and methods useable for treating frontal sinusitis
US8951225B2 (en) 2005-06-10 2015-02-10 Acclarent, Inc. Catheters with non-removable guide members useable for treatment of sinusitis
US7816975B2 (en) * 2005-09-20 2010-10-19 Hewlett-Packard Development Company, L.P. Circuit and method for bias voltage generation
US8114113B2 (en) 2005-09-23 2012-02-14 Acclarent, Inc. Multi-conduit balloon catheter
US9820688B2 (en) 2006-09-15 2017-11-21 Acclarent, Inc. Sinus illumination lightwire device
US8439687B1 (en) 2006-12-29 2013-05-14 Acclarent, Inc. Apparatus and method for simulated insertion and positioning of guidewares and other interventional devices
WO2008124787A2 (en) 2007-04-09 2008-10-16 Acclarent, Inc. Ethmoidotomy system and implantable spacer devices having therapeutic substance delivery capability for treatment of paranasal sinusitis
US8118757B2 (en) 2007-04-30 2012-02-21 Acclarent, Inc. Methods and devices for ostium measurement
US8485199B2 (en) 2007-05-08 2013-07-16 Acclarent, Inc. Methods and devices for protecting nasal turbinate during surgery
US10206821B2 (en) 2007-12-20 2019-02-19 Acclarent, Inc. Eustachian tube dilation balloon with ventilation path
US8182432B2 (en) 2008-03-10 2012-05-22 Acclarent, Inc. Corewire design and construction for medical devices
KR101653180B1 (ko) 2008-07-30 2016-09-01 아클라런트, 인코포레이션 부비 개구 탐지기 장치 및 방법
RU2506056C2 (ru) 2008-09-18 2014-02-10 Аккларент, Инк. Способы и аппарат для лечения заболеваний уха, горла, носа
US20100241155A1 (en) 2009-03-20 2010-09-23 Acclarent, Inc. Guide system with suction
US7978742B1 (en) 2010-03-24 2011-07-12 Corning Incorporated Methods for operating diode lasers
US8435290B2 (en) 2009-03-31 2013-05-07 Acclarent, Inc. System and method for treatment of non-ventilating middle ear by providing a gas pathway through the nasopharynx
US9155492B2 (en) 2010-09-24 2015-10-13 Acclarent, Inc. Sinus illumination lightwire device
US9433437B2 (en) 2013-03-15 2016-09-06 Acclarent, Inc. Apparatus and method for treatment of ethmoid sinusitis
US9629684B2 (en) 2013-03-15 2017-04-25 Acclarent, Inc. Apparatus and method for treatment of ethmoid sinusitis
JP7080828B2 (ja) 2016-05-27 2022-06-06 ライフ テクノロジーズ コーポレーション 生物学的データに対するグラフィカルユーザインターフェースのための方法およびシステム
ES2969301T3 (es) * 2017-02-02 2024-05-17 Otolanum Ag Composición intranasal que comprende betahistina
WO2018170532A1 (en) * 2017-03-22 2018-09-27 Franz, Lilian Ann Treatment method
AU2019208152B2 (en) * 2017-03-22 2021-07-01 Burkhard Karl-Heinz Gunther Franz Treatment method
FI3600276T3 (fi) 2017-03-28 2023-06-29 Intrabio Ltd Betahistiini tai sen farmaseuttisesti hyväksyttävä suola ja monoamiinioksidaasin inhibiittori käytettäväksi yhden tai useamman huimausoireen hoitamisessa tai ehkäisemisessä kohteessa

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149034A (en) 1961-07-17 1964-09-15 Umimed Inc Method of relieving pain with (pyridyllower alkyl)-amines
US3632765A (en) 1969-07-18 1972-01-04 Unimed Inc Treatment of shock
GB1241906A (en) * 1969-11-01 1971-08-04 Unimed Inc Salts of beta-(pyridyl alkyl) amines with 21-hydroxy steroid polybasic acid esters
JPS5938202B2 (ja) 1976-03-05 1984-09-14 エーザイ株式会社 難聴治療剤
GB1577871A (en) 1976-05-28 1980-10-29 Unimed Inc Prevention of myocardial infarction
FR2397840B1 (https=) * 1977-07-22 1981-03-20 Cherqui Jean
FR2432313A1 (fr) 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention
JPS55154915A (en) * 1979-05-21 1980-12-02 Jiyan Sadeia Shieruki Medicine mold
DE3634016A1 (de) 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
IT1229237B (it) 1989-05-08 1991-07-26 Prodotti Formenti Sali di (2-(piridil)etil) metilammina
GB9104854D0 (en) 1991-03-07 1991-04-17 Reckitt & Colmann Prod Ltd Sustained release compositions
JPH06219947A (ja) 1993-01-26 1994-08-09 Kinki Univ 経皮投与製剤
GB2280604B (en) 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
IT1309591B1 (it) 1999-03-05 2002-01-24 Formenti Farmaceutici Spa Composizioni a rilascio controllato di betaistina.
JP2001064205A (ja) 1999-06-25 2001-03-13 Dai Ichi Seiyaku Co Ltd 製剤組成物
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US20020106408A1 (en) 2000-12-01 2002-08-08 Johnatan Bacon Prolamin-based sustained-release compositions and delayed-onset compositions
AU2002240359A1 (en) 2001-02-14 2002-08-28 Sarfaraz K. Niazi Pharmaceutical composition for the treatment of alopecia
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
WO2002094240A1 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of physiologically active compounds through an inhalation route
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Pharmaceuticals, Inc. Delivery of drug esters through an inhalation route
WO2003026631A1 (en) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
WO2004089313A2 (en) 2003-04-01 2004-10-21 Transform Pharmaceuticals, Inc. Novel olanzapine forms and related methods of treatment
WO2003077902A1 (en) 2002-02-19 2003-09-25 Xenoport, Inc. Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
EP1511490A4 (en) 2002-05-31 2009-03-11 Transform Pharmaceuticals Inc NOVEL CONAZOLE CRYSTALLINE FORMS AND RELATED METHODS, PHARMACEUTICAL COMPOSITIONS AND METHODS
GB0213869D0 (en) 2002-06-17 2002-07-31 Arakis Ltd The treatment of pain
AU2003281158A1 (en) * 2002-07-12 2004-02-02 Arakis Ltd. The treatment of emesis
UA84277C2 (ru) 2002-10-25 2008-10-10 Лабофарм Инк. Композиция трамадола с пролонгированным высвобождением с 24-часовым действием
US8487002B2 (en) 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
MXPA05004410A (es) 2002-10-25 2005-11-23 Labopharm Inc Composiciones de liberacion controlada.
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
DE60320965D1 (de) 2003-07-04 2008-06-26 Formenti Farmaceutici Spa Betahistinezubereitungen mit kontrollierter Freisetzung
WO2005011665A1 (en) * 2003-07-22 2005-02-10 Arakis Ltd. The use of proglumide for the treatment of emesis
BRPI0506807A (pt) 2004-04-22 2007-05-29 Mor Research Applic Ltd método de gerenciamento de consumo de alimento e composição farmacológica
CN1568986A (zh) 2004-05-13 2005-01-26 南昌弘益科技有限公司 盐酸倍他司汀滴丸及其制备方法
GB0506800D0 (en) 2005-04-04 2005-05-11 Merck Sharp & Dohme New uses
CA2605341A1 (en) 2005-05-09 2006-11-16 Drugtech Corporation Modified-release pharmaceutical compositions
US20070009564A1 (en) 2005-06-22 2007-01-11 Mcclain James B Drug/polymer composite materials and methods of making the same
WO2007011707A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Polymer coatings containing drug powder of controlled morphology
CN1732934B (zh) 2005-08-10 2011-10-05 陈学峰 注射用盐酸倍他司汀冻干粉针剂及其制备方法
US8158152B2 (en) 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
US8119668B2 (en) 2005-12-23 2012-02-21 Nelson Erik B Treatment methods employing histamine H3 receptor antagonists, including betahistine
US7951845B2 (en) 2006-01-19 2011-05-31 The Regents Of The University Of Michigan Composition and method of treating hearing loss
US20070231390A1 (en) 2006-03-29 2007-10-04 Andrx Labs, Llc Formulations including hygroscopic compounds
RU2308941C1 (ru) 2006-05-10 2007-10-27 Открытое акционерное общество "Московское производственное химико-фармацевтическое объединение им. Н.А. Семашко" Твердая лекарственная форма, обладающая гистаминоподобным действием, и способ ее получения
US20080066739A1 (en) 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
CN101668544B (zh) * 2006-12-26 2013-04-24 株式会社新日本科学 经鼻投用制剂
AU2008214380A1 (en) 2007-02-02 2008-08-14 Colucid Pharmaceuticals, Inc. Compounds that inhibit cholinesterase

Similar Documents

Publication Publication Date Title
JP2011520992A5 (https=)
EA022565B1 (ru) Способы лечения млекопитающих с дисфункциями евстахиевой трубы
PH12018501807A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of diseas
JP2010513478A5 (https=)
JP2008044951A5 (https=)
JP2011201907A5 (https=)
MX2015016344A (es) Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades.
JP2012255026A5 (https=)
JP2014530220A5 (https=)
JP2010222367A5 (https=)
JP2007106777A5 (https=)
MD4369B1 (ro) Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei
BR112013026257A2 (pt) derivados de glicosídeo e usos dos mesmos para o tratamento de diabetes
ZA202213478B (en) Osmotic dosage forms comprising deutetrabenazine and methods of use thereof
AR086800A1 (es) Composicion farmaceutica oftalmologica topica que contiene regorafenib
WO2012112447A3 (en) Histone deacetylase inhibitors and methods of use thereof
JP2016515550A5 (https=)
CO2019008657A2 (es) Composición intranasal que comprende betahistina
AR085273A1 (es) Formulacion liquida libre de propelente que comprende una droga antimuscarinica
RU2013157398A (ru) Композиция
UY30126A1 (es) Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones
JP2009506002A5 (https=)
JP2015512948A5 (https=)
RU2013142445A (ru) Фармацевтический препарат для местного применения, содержащий в-220
JP2009536193A5 (https=)